Journals / Klinik Psikiyatri Dergisi / 2020 / Cilt: 23 - Sayı: 1

COVID 19 pandemic and psychotic symptoms

COVID-19 pandemisi ve psikotik belirtiler

Pages
81–85
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Furthermore, psychosocial stress during the pandemic and plausible associations between the coronaviruses and psychotic symptoms will be discussed in light of the previous research.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:COVID-19 pandemic causes substantial psychosocial stress on individuals and the community.
📊
Key Findings & Data:Due to social isolation, neurotrophic potential of coronaviruses and the inflammatory processes, occurrence and relapse of psychotic symptoms may increase during the pandemic.
💡
Conclusion & Impact:Furthermore, psychosocial stress during the pandemic and plausible associations between the coronaviruses and psychotic symptoms will be discussed in light of the previous research.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

COVID-19 pandemic causes substantial psychosocial stress on individuals and the community. Due to social isolation, neurotrophic potential of coronaviruses and the inflammatory processes, occurrence and relapse of psychotic symptoms may increase during the pandemic. Furthermore, pandemic has limited some protective factors for psychosis (i.e. social support, community mental health practices and physical activity). Additionally, admission of individuals suffering from psychotic symptoms may decrease due to risk of viral contamination. This may lead to under-detection of the problem, persistence of psychotic symptoms, poorer prognosis and more severe outcomes. Psychotic symptoms were reported among infected individuals during the recent coronavirus outbreaks (SARS CoV-1 and MERS CoV). Furthermore, mental problems were of the most substantial causes of long term disability associated with these outbreaks. In this paper, limited data on psychotic symptoms during the COVID-19 pandemic will be reviewed. Furthermore, psychosocial stress during the pandemic and plausible associations between the coronaviruses and psychotic symptoms will be discussed in light of the previous research.

Özet

COVID-19 pandemisi bireylerde ve toplumda önemliölçüde psikososyal strese neden olmaktadır. Yaşanılansosyal izolasyon süreçleri, koronavirüslerin nörotrofikpotansiyeli ve enflamatuar süreçler nedeniyle de pandemi ortamında psikotik belirtilerin ortaya çıkmasında vealevlenmesinde artış olabileceği düşünülmektedir. Aynızamanda pandemi ortamı psikoz açısından koruyucuetkenlerin (sosyal destek ağı, toplum ruh sağlığıuygulamaları, fiziksel aktivite) kısıtlanmasına nedenolmaktadır. Bununla birlikte bulaş riski psikotik belirtileryaşayan bireylerin başvurularını azaltmaktadır. Bu durummevcut problemin yeterince tespit edilememesine,psikozun kalıcılaşması, daha ağır seyretmesi ve dahafazla yıkıcı etkisinin olması ile sonuçlanabilir. Yakındönemde yaşanan koronavirüs salgınlarında (SARS CoV1 ve MERS CoV) virüse maruz kalan kişilerde psikotikbelirtilerin görüldüğü bildirilmiştir. Salgınlarla ilişkili uzundönemli yeti yetimi nedenleri arasında ruhsal bozukluklarönemli bir yer kaplamaktadır. Bu yazıda COVİD-19 pandemisinde bildirilen psikotik belirtiler ile ilgili bilimselkaynaklarda yer alan kısıtlı veri gözden geçirilecektir.Ayrıca pandemi ortamındaki psikososyal stres, koronavirüsler ve psikotik belirtiler arasındaki olası ilişkiler,konu üzerine yapılmış araştırmalardan edinilen verilerışığında tartışılacaktır.

🔖

Cite This Article

KIRLI, U., BİNBAY, İ. T., ELBİ, H., ALPTEKİN, K. (2020). COVID 19 pandemic and psychotic symptoms. Klinik Psikiyatri Dergisi, Cilt: 23 - Sayı: 1, 81–85. https://ajindex.com/articles/343623

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Brown E, Gray R, Lo Monaco S, O'Donoghue B, Nelson B, Thompson A, Francey S, McGorry P. The potential impact of COVID-19 on psychosis: A rapid review of contemporary epidemic and pandemic research. Schizophr Res. 2020; S0920- 9964(20)30257-7. doi:10.1016/j.schres.2020.05.005. [In press]
  2. World Health Organisation. Mental health and psychosocial considerations during the COVID-19 outbreak. https://www.who.int/publications-detail/WHO-2019-nCoVMentalHealth-2020.1. Erisim tarihi: Mayıs 16, 2020
  3. Voineskos AN, Stergiopoulos V, Mulsant BH, Kozloff N. The COVID-19 Global Pandemic: Implications for People With Schizophrenia and Related Disorders. Schizophr Bull. 2020;46:752-757
  4. Sheng B, Wing Cheng SK, Lau KK, Li HL, Yiu Chan EL. The effects of disease severity, use of corticosteroids and social factors on neuropsychiatric complaints in severe acute respiratory syndrome (SARS) patients at acute and convalescent phases. Eur Psychiatry. 2020;20:236-242
  5. Sekar A, Bialas AR, de Rivera H, Davis A, Hammond TR, Kamitaki N, Tooley K, Presumey J, Baum M, Van Doren V, Genovese G, Rose SA, Handsaker RE, Daly MJ, Carroll MC, Stevens B, McCarroll SA. Schizophrenia risk from complex variation of complement component 4. Nature. 2016;530(7589):177- 183
  6. Troyer EA, Kohn JN, Hong S. Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms. Brain Behav Immun. 2020;87:34-39
  7. Kępińska AP, Iyegbe CO, Vernon AC, Yolken R, Murray RM, Pollak TA. Schizophrenia and Influenza at the Centenary of the 1918-1919 Spanish Influenza Pandemic: Mechanisms of Psychosis Risk. Front Psychiatry. 2020;11. doi: 10.3389/fpsyt.2020.00072. [In press]
  8. Von Economo C. Encephalitis Lethargica, Its Sequelae and Treatment. JAMA. 1932;98(3):255
  9. Kim J-E, Heo J-H, Kim H-o, Song S-h, Park S-S, Park T-H, Ahn J-Y, Kim M-K, Choi J-P. Neurological Complications during Treatment of Middle East Respiratory Syndrome. J Clin Neurol. 2017;13(3):227
  10. Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, Chang J, Hong C, Zhou Y, Wang D, Miao X, Li Y, Hu B. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurology. 2020;77(6):683
  11. Helms J, Kremer S, Merdji H, Clere-Jehl R, Schenck M, Kummerlen C, Collange O, Boulay C, Fafi-Kremer S, Ohana M, Anheim M, Meziani F. Neurologic Features in Severe SARSCoV-2 Infection. N Engl J Med. 2020;382(23):2268-2270
  12. Hu W, Su L, Qiao J, Z